TOP TEN perturbations for 38954_at (Homo sapiens)
Organism: Homo sapiens
Gene: 38954_at
Selected probe(set): 205946_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 38954_at (205946_at) across 6674 perturbations tested by GENEVESTIGATOR:
glioma study 17 (oligoastrocytoma; unsorted) / non-tumor cortical tissue
Relative Expression (log2-ratio):2.787815Number of Samples:2 / 4
Experimental | glioma study 17 (oligoastrocytoma; unsorted) |
Brain cells isolated from low grade oligoastrocytoma (grade II). Tumor tissue was dissociated using enzymatic treatment and all cells were used for RNA isolation. | |
Control | non-tumor cortical tissue |
Cortical tissue obtained from patients with epilepsy, but without any manifested brain cancer. The tissue was dissociated using enzymatic treatment, but all brain cell types were used for analyses. |
brain tumor study 1 (pilocytic astrocytoma) / brain tumor study 1 (ependymoma)
Relative Expression (log2-ratio):-1.6996984Number of Samples:15 / 46
Experimental | brain tumor study 1 (pilocytic astrocytoma) |
Primary tumor tissue sample from the brain of patients with pilocytic astrocytoma. | |
Control | brain tumor study 1 (ependymoma) |
Primary tumor tissue sample from the brain of patients with ependymoma. |
influenza virus study 11 (A/H5N3) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.6208506Number of Samples:3 / 3
Experimental | influenza virus study 11 (A/H5N3) |
Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F119/3/1997(H5N3). Samples were taken 10 hours post-infection. | |
Control | influenza virus study 4 (A/H1N1) |
Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
brain tumor study 1 (glioblastoma) / brain tumor study 1 (ependymoma)
Relative Expression (log2-ratio):-1.565525Number of Samples:34 / 46
Experimental | brain tumor study 1 (glioblastoma) |
Primary tumor tissue sample from the brain of patients with glioblastoma multiformae. | |
Control | brain tumor study 1 (ependymoma) |
Primary tumor tissue sample from the brain of patients with ependymoma. |
ovarian tumor study 11 (low grade) / normal ovarian surface epithelial cell sample
Relative Expression (log2-ratio):-1.50595Number of Samples:11 / 6
Experimental | ovarian tumor study 11 (low grade) |
Human microdissected tumor cells from the ovary of patients with low grade serous carcinoma. | |
Control | normal ovarian surface epithelial cell sample |
Human microdissected ovarian surface epithelial cell sample from the ovary of healthy individuals. |
influenza virus study 10 (A/H5N2) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.4829168Number of Samples:3 / 3
Experimental | influenza virus study 10 (A/H5N2) |
Human carcinoma cell line A549 infected with influenza A virus subtype influenza virus A/duck/Malaysia/F189/07/2004(H5N2). Samples were taken 10 hours post-infection. | |
Control | influenza virus study 4 (A/H1N1) |
Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |
pancreatic cancer study 3 (ipmn) / normal pancreas tissue
Relative Expression (log2-ratio):-1.4145727Number of Samples:3 / 6
Experimental | pancreatic cancer study 3 (ipmn) |
Intraductal papillary mucinous neoplasm from patients with pancreatic cancer. | |
Control | normal pancreas tissue |
Normal human pancreatic tissue. |
ovarian tumor study 11 (borderline) / normal ovarian surface epithelial cell sample
Relative Expression (log2-ratio):-1.4098682Number of Samples:8 / 6
Experimental | ovarian tumor study 11 (borderline) |
Human microdissected tumor cells from the ovary of patients with low-malignant (borderline) tumors of the ovary. | |
Control | normal ovarian surface epithelial cell sample |
Human microdissected ovarian surface epithelial cell sample from the ovary of healthy individuals. |
hepatitis C study 6 (under treatment; non-responder) / hepatitis C study 6 (before treatment)
Relative Expression (log2-ratio):1.4017782Number of Samples:5 / 9
Experimental | hepatitis C study 6 (under treatment; non-responder) |
Microdissected liver-infiltrating lymphocyte (lilym) samples obtained after liver tissue biopsy from chronic hepatitis C (CH-C) patients after treatment with interferon-alpha 2b (IFN-a 2b) and ribavirin (Rib) in combination. Patients received IFN-a 2b (6 MU , every day for 2 weeks, then three times a week for 22 weeks) and Ribavirin (10–13 mg/kg/day) combination therapy for 24 weeks. Individuals had no treatment success and were for that non-responders after HCV viremia detected at the cessation of therapy. | |
Control | hepatitis C study 6 (before treatment) |
Microdissected liver-infiltrating lymphocyte (lilym) samples obtained after liver tissue biopsy from chronic hepatitis C (CH-C) patients before treatment with interferon-alpha 2b (IFN-a 2b) and ribavirin (Rib). |
influenza virus study 9 (A/pH1N1) / influenza virus study 4 (A/H1N1)
Relative Expression (log2-ratio):-1.3920898Number of Samples:3 / 3
Experimental | influenza virus study 9 (A/pH1N1) |
Human carcinoma cell line A549 infected with influenza A virus subtype [A/Singapore/478/2009 (pH1N1)]. Samples were taken 10 hours post-infection. | |
Control | influenza virus study 4 (A/H1N1) |
Human carcinoma cell line A549 infected with influenza A virus subtype A/WSN/33 (H1N1). Samples were taken 10 hours post-infection. |